The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 521-540

  Cooper, N G F ^a   Laabich, A ^b   Fan, W ^a   Wang, X ^a  

^a University of Louisville School of Medicine   (United States)

^b Acucela Inc   (United States)

Author keywords

amacrine cell; anti apoptotic genes; autocamtide 2 related inhibitory peptide; BDNF; brain derived neurotrophic factor; calcium calmodulin dependent protein kinase II; CaMKII ; CaMKII B; caspase 3; cell death pathway; cell survival pathway; glutamate; NMDA; pro apoptotic genes; retinal ganglion cell

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DIZOCILPINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIC FACTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

CELL DEATH; CELL SURVIVAL; CLINICAL TRIAL; DEGENERATIVE DISEASE; GLAUCOMA; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CASPASE 3; CELL DEATH; CELL SURVIVAL; EXCITATORY AMINO ACID ANTAGONISTS; GLAUCOMA; HUMANS; ISOENZYMES; N-METHYLASPARTATE; NERVE GROWTH FACTORS; PEPTIDES; PHOTOPERIOD; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 53049107598     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01136-9     Document Type: Review

References (136)

1. Areosa S.A., Sherriff F., and McShane R. Memantine for dementia. Cochrane Database Syst. Rev. 20 3 (2005) CD003154
2. Armaly M.F., Krueger D.E., Maunder L., Becker B., Hetherington Jr. J., Kolker A.E., Levene R.Z., Maumenee A.E., Pollack I.P., and Shaffer R.N. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch. Ophthalmol. 98 (1980) 2163-2171
3. Armstrong R.C., Aja T.J., Hoang K.D., Gaur S., Bai X., Alnemri E.S., Litwack G., Karanewsky D.S., Fritz L.C., and Tomaselli K.J. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17 (1997) 553-562
4. 2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature 359 (1992) 417-420
5. Bennett J.L., Zeiler S.R., and Jones K.R. Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2996-3005
6. Bosco A., and Linden R. BDNF and NT-4 differentially modulate neurite outgrowth in developing retinal ganglion cells. J. Neurosci. Res. 57 (1999) 759-769
7. Bova R. BDNF and TrkB mRNAs oscillate in rat brain during the light-dark cycle. Brain Res. Mol. Brain Res. 57 (1998) 321-324
8. Bronstein J.M., Farber D.B., and Wasterlain C.G. Regulation of type-II calmodulin kinase: functional implications. Brain Res. Revs. 18 (1993) 135-147
9. Bronstein J.M., Wasterlain C.G., Bok D., Lasher R., and Farber B.D. Localization of retinal calmodulin kinase. Exp. Eye Res. 47 (1988) 391-402
10. Bronstein J.M., Wasterlain C.G., and Farber B.D. A retinal calmodulin-dependent kinase: calcium/calmodulin-stimulated and inhibited states. J. Neurochem. 50 (1988) 438-446
11. Bronstein J.M., Wasterlain C.G., Lasher R., and Farber B.D. Dark-induced changes in activity and compartmentalization of retinal calmodulin kinase in the rat. Brain Res. 495 (1989) 83-88
12. Chaudhary P., Ahmed F., and Sharma S.C. MK801-a neuroprotectant in rat hypertensive eyes. Brain Res. 792 (1998) 154-158
13. Chaum E. Retinal neuroprotection by growth factors: a mechanistic perspective. J. Cell Biochem. 88 (2003) 57-75
14. Chen H., and Weber A.J. Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res. 1011 (2004) 99-106
15. Chen J.C., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., and Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18 (1998) 4914-4928
16. Chen L., and Huang L.Y.M. Protein kinase C reduces magnesium block of NMDA-receptor channels as a mechanism of modulation. Nature 356 (1992) 521-523
17. Chidlow G., Wood J.P.M., and Casson R.J. Pharmacological neuroprotection for glaucoma. Drugs 67 (2007) 725-759
18. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
19. 2+/calmodulin-dependent protein kinase II and a novel related protein in the developing retina. J. Mol. Neurosci. 6 (1995) 75-89
20. de Erausquin G.A., Hyrc K., Dorsey D.A., Mamah D., Dokucu M., Masco D.H., Walton T., Dikranian K., Soriano M., Verdugo J.M.G., Goldberg M.P., and Dugan L.L. Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Mol. Pharmacol. 63 (2003) 784-790
21. Diijik F., van Leeuwen S., and Kamphius W. Differential effects of ischemia/reperfusion on amacrine cell subtype-specific transcript levels in the rat retina. Brain Res. 1026 (2004) 194-204
22. Dkhissi O., Chanut E., Versaux-Botteri C., Minvielle F., Trouvin J.H., and Nguyen-Legros J. Changes in retinal dopaminergic cells and dopamine rhythmic metabolism during the development of a glaucoma-like disorder in quails. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2335-2344
23. Dkhissi O., Chanut E., Versaux-Botteri C., Trouvin J.H., Reperant J., and Nguyen-Legros J. Day and night dysfunction in intraretinal melatonin and related indoleamines metabolism, correlated with the development of glaucoma-like disorder in an avian model. J. Neuroendocrinol. 10 (1998) 863-869
24. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114 (1996) 299-305
25. Fan W., Agarwal N., and Cooper N.G.F. The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res. 1067 (2006) 48-57
26. Fan W., Agarwal N., Kumar M.D., and Cooper N.G.F. Retinal ganglion cell death and neuroprotection: involvement of the CaMKII-alpha gene. Brain Res. Mol. Brain Res. 139 (2005) 306-316
27. B mediates a survival response in retinal ganglion cells subjected to a glutamate stimulus. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3854-3863
28. Flammer J. The vascular concept of glaucoma. Surv. Ophthalmol. 38 Suppl. (1994) S3-S6 Review
29. Fukunaga K., and Soderling T.R. Activation of calcium/calmodulin-dependent kinase II in cerebellar granule cells by N-methyl-d-aspartate receptor activation. Mol. Cell. Neurosci. 1 (1990) 133-138
30. 2+/calmodulin-dependent protein kinase II and protein kinase C by glutamate in cultured rat neurons. J. Biol. Chem. 267 (1992) 22527-22533
31. Gao H., Qiao X., Hefti F., Hollyfield J.G., and Knusel B. Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1840-1847
32. Garcia M., Forster V., Hicks D., and Vecino E. In vivo expression of neurotrophins and neurotrophin receptors is conserved in adult porcine retina in vitro. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4532-4541
33. Gaudilliere B., Konishi Y., de la Iglesia N., Yao G.l., and Bonni A. A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. Neuron 41 (2004) 229-241
34. Gavrielli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119 (1992) 493-501
35. Goldberg M.P., and Choi D.W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent protein kinase mechanism of neuronal injury. J. Neurosci. 13 (1993) 3510-3524
36. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., and Wang K.W. A specific inhibitor of calcium/calmodulin-dependent protein kinase II provides neuroprotection against NMDA and Hypoxia/Hypoglycemia induced cell death. J. Neurosci. 15 (1995) 4093-4101
37. Hama Y., Katsuki H., Tochikawa Y., Suminaka C., Kume T., and Akaike A. Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo. Neurosci. Res. 56 (2006) 279-285
38. Hamassaki-Britto D.E., Hermans-Borgmeyer I., Heinemann S., and Hughes T.E. Expression of glutamate receptors genes in the mammalian retina: the localization of GluR7 mRNAs. J. Neurosci. 13 (1993) 1888-1898
39. Hare W., WoldeMussie E., Lai R., Ton H., Ruiz G., Feldmann B., Wijono M., Chun T., and Wheeler L. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv. Ophthalmol. 45 suppl. 3 (2001) S284-S289
40. Hartveit E., Brandstatter J.H., Enz R., and Wassle H. Expression of the mRNA of seven metabotropic glutamate receptors (mGluR1 to 7) in the rat retina. An in situ hybridization study on tissue sections and isolated cells. Eur. J. Neurosci. 7 (1995) 1472-1483
41. Hinds H.L., Goussakov I., Nakazawa K., Tonegawa S., and Bolshakov V.Y. Essential function of alpha-calcium/calmodulin-dependent protein kinase II in neurotransmitter release at a glutamatergic central synapse. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4275-4280
42. Hof P.R., Lee P.Y., Yeung G., Wang R.F., Podos S.M., and Morrison J.H. Glutamate receptor subunit GluR2 and NMDAR1 immunoreactivity in the retina of macaque monkeys with experimental glaucoma does not identify vulnerable neurons. Exp. Neur. 153 (1998) 234-241
43. Honjo M., Tainihara H., Inatani M., Kido N., Sawamura T., Yue B.Y., Narumiya S., and Honda Y. Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42 (2001) 137-144
44. Honkanen R.A., Baruah S., Zimmerman M.B., Khanna C.L., Weaver Y.K., Narkiewicz J., Waziri R., Gehrs K.M., Weingeist T.A., Boldt H.C., Folk J.C., Russell S.R., and Kwon Y.H. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch. Ophthlmol. 121 (2003) 183-188
45. Hood D.C., Greenstein V., Frishman L., Holopigian K., Viswanathan S., Seiple W., Ahmed J., and Robson J.G. Identifying inner retinal contributions to the human multifocal ERG. Vis. Res. 39 (1999) 2285-2291
46. Hood D.C., and Zhang X. Multifocal ERG and VEP responses and visual fields: comparing disease-related changes. Doc. Ophthalmol. 100 (2000) 115-137
47. Ishida A., Kameshita I., Okuno S., Kitani T., and Fujisawa H. A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem. Biophys. Res. Comm. 212 (1995) 806-812
48. Ishida A., Shigeri Y., Tatsu Y., Uegaki K., Kameshita I., Okuno S., Kitani T., Yumoto N., and Fujisawa H. Critical amino acid residues of AIP, a highly specific inhibitory peptide of calmodulin-dependent protein kinase II. FEBS Lett. 427 (1998) 115-118
49. Jiang X., Zhu D., Okagaki P., Lipsky R., Wu X., Banaudha K., Mearow K., Strauss K.I., and Marini A.M. N-methyl-d-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons. Ann. N. Y. Acad. Sci. 993 (2003) 134-145
50. Johnson J.E., Barde Y.A., Schwab M., and Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J. Neurosci. 6 (1986) 3031-3038
51. Kaiser H.J., Flammer J., and Burckhardt D. Silent myocardial ischemia in glaucoma patients. Ophthalmologica 207 (1993) 6-7
52. Kawai S.I., Vora S., Das S., Gachie E., Becker B., and Neufeld A.H. Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation, and glaucoma. FASEB J. 15 (2001) 1285-1287
53. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., and Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 115 (1997) 1031-1035
54. Kido N., Tanihara H., Honjo M., Inatani M., Tatsuno T., Nakayama C., and Honda Y. Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death. Brain Res. 884 (2000) 59-67
55. Kielczewski J.L., Pease M.E., and Quigley H.A. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3188-3196
56. King A.E., Dickson T.C., Blizzard C.A., Foster S.S., Chung R.S., West A.K., Chuah M.I., and Vickers J.C. Excitotoxicity mediated by non-NMDA receptors causes distal axonopathy in long-term cultured spinal motor neurons. Eur. J. Neurosci. 26 (2007) 2151-2159
57. Kitamura Y., Miyazaki A., Yamanaka Y., and Nomura Y. Stimulatory effects of protein kinase C and calmodulin kinase II on N-methyl-d-aspartate receptor/channels in the postsynaptic density of rat brain. J. Neurochem. 61 (1993) 100-109
58. 2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J. Neurochem. 71 (1998) 1390-1395
59. Ko M.L., Hu D.N., Ritch R., and Sharma S.C. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2967-2971
60. Kolarow R., Brigadski T., and Lessmann V. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J. Neurosci. 27 (2007) 10350-10364
61. Krishnamoorthy R.R., Agarwal P., Prasanna G., Vopat K., Lambert W., Sheedlo H.J., Pang I.H., Shade D., Wordinger R.J., Yorio T., Clark A.F., and Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res. Mol. Brain Res. 86 (2001) 1-12
62. Laabich A., and Cooper N.G.F. Regulation of calcium/calmodulin-dependent protein kinase II in the adult rat retina is mediated by ionotropic glutamate receptors. Exp. Eye Res. 68 (1999) 703-713
63. Laabich A., and Cooper N.G.F. Neuroprotective effect of AIP on N-methyl-d-aspartate-induced cell death in retinal neurons. Brain Res. Mol. Brain Res. 85 (2000) 32-40
64. Laabich A., Li G.Y., and Cooper N.G.F. Calcium/calmodulin-dependent protein kinase II containing a nuclear localizing signal is altered in retinal neurons exposed to N-methyl-d-aspartate. Brain Res. Mol. Brain Res. 76 (2000) 253-265
65. Laabich A., Li G., and Cooper N.G.F. Characterization of apoptosis-genes associated with NMDA mediated cell death in the adult rat retina. Mol. Brain Res. 91 (2001) 34-42
66. Lambert W.S., Clark A.F., and Wordinger R.J. Neurotrophin and Trk expression by cells of the human lamina cribrosa following oxygen-glucose deprivation. BMC Neurosci. 5 (2004) 51-65
67. Leske M.C. The epidemiology of open-angle glaucoma: a review. Am. J. Epidemiol. 118 (1983) 166-191
68. Lessmann V., Gottmann K., and Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69 (2003) 341-374
69. Li G., Laabich A., Liu L.O., Xue J., and Cooper N.G. Molecular cloning and sequence analyses of calcium/calmodulin-dependent protein kinase II from fetal and adult human brain. Sequence analyses of human brain calcium/calmodulin-dependent protein kinase II. Mol. Biol. Rep. 28 (2001) 35-41
70. Lilienbaum A., and Israel A. From calcium to NF-{kappa}B signaling pathways in neurons. Mol. Cell. Biol. 23 (2003) 2680-2698
71. Lonngren U., Napankangas U., Lafuente M., Mayor S., Lindqvist N., Vidal-Sanz M., and Hallbook F. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment. Brain Res. Bull. 71 (2006) 208-218
72. Lucas D.R., and Newhouse J.P. The toxic effect of sodium l-glutamate on the inner layers of the retina. AMA Arch. Ophthalmol. 58 (1957) 193-201
73. Marcoux F.W., Probert A.W., and Weber M.L. Hypoxic neuronal injury in tissue culture is associated with delayed calcium accumulation. Stroke 21 Suppl. III (1990) 71-74
74. Marini A.M., Jiang X., Wu X., Tian F., Zhu D., Okagaki P., and Lipsky R.H. Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype. Restor. Neurol. Neurosci. 22 (2004) 121-130
75. Martin K.R., Quigley H.A., Zack D.J., Levkovitch-Verbin H., Kielczewski J., Valenta D., Baumrind L., Pease M.E., Klein R.L., and Hauswirth W.W. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4357-4365
76. Matthews R.P., Guthrie C.R., Wailes L.M., Zhao X., Means A.R., and McKnight G.S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell Biol. 14 (1994) 6107-6116
77. Mattson M.P., Culmsee C., Yu Z., and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74 (2000) 443-456
78. Mattson M.P., Keller J.N., and Begley J.G. Evidence of synaptic apoptosis. Exp. Neurol. 153 (1998) 35-48
79. May C.A., and Mittag T. Neuronal nitric oxide synthase (nNOS) positive retinal amacrine cells are altered in the DBA/2NNia mouse, a murine model for angle-closure glaucoma. J. Glaucoma. 13 (2004) 496-499
80. McGlade-McCulloh E., Yamamoto H., Tan S.E., Brickey D.A., and Soderling T.R. Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature 362 (1993) 640-642
81. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., and Baltimore D. NF-kappa B functions in synaptic signaling and behavior 73. Nat. Neurosci. 6 (2003) 1072-1078
82. Meisner F., Scheller C., Kneitz S., Sopper S., Neuen-Jacob E., Riederer P., Meulen V.T., and Koutsilieri E. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33 (2008) 2228-2236
83. Mey J., and Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 602 (1993) 304-317
84. Misra R.P., Bonni A., Miranti C.K., Rivera V.M., Sheng M., and Greenberg M.E. L-type voltage-sensitive calcium channel activation stimulates gene expression by a serum response factor-dependent pathway. J. Biol. Chem. 269 (1994) 25483-25493
85. Mo X., Yokoyama A., Oshitari T., Negishi H., Dezawa M., Mizota A., and Adachi-Usami E. Rescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2401-2405
86. Moon J.I., Kim I.B., Gwon J.S., Park M.H., Kang T.H., Lim E.J., Choi K.R., and Chun M.H. Changes in retinal neuronal populations in the DBA/2J mouse. Cell Tissue Res. 320 1 (2005) 51-59
87. 2+/calmodulin-dependent protein kinase II activity in cultured rat hippocampal neurons. J. Neurochem. 64 (1995) 2132-2139
88. Murphy J.A., and Clarke D.B. Target-derived neurotrophins may influence the survival of adult retinal ganglion cells when local neurotrophic support is disrupted: implications for glaucoma. Med. Hypotheses 67 (2006) 1208-1212
89. Namura N., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., and Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18 10 (1998) 3659-3668
90. Nickells R.W. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv. Ophthalmol. 43 (1999) 151-161
91. Nucci C., Tartaglione R., Rombola L., Morrone L.A., Fazzi E., and Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26 (2005) 935-941
92. 2+/calmodulin-dependent protein kinase II in the rat retina. Brain Res. 634 (1994) 257-265
93. Osborne N.N., Casson R.J., Wood J.P.M., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
94. Osborne N.N., Ugarte M., Chao M., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 Suppl 1 (1999) S102-S128
95. Pang I.H., Wexler E.M., Nawys S., Desantis L., and Kapin M.A. Protection by eliprodil against excitotoxicity in cultured rat retinaganglion cells. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1170-1176
96. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., and Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41 (2000) 764-774
97. Peinado-Ramon P., Salvador M., Villegas-Perez M.P., and Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells: a quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37 (1996) 489-500
98. Pizzi M., Goffi F., Boroni F., Benarese M., Perkins S.E., Liou H.C., and Spano P. Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J. Biol. Chem. 277 (2002) 20717-20723
99. Pollock G.S., Vernon E., Forbes M.E., Yan Q., Ma Y.T., Hsieh T., Robichon R., Frost D.O., and Johnson J.E. Effects of early visual experience and diurnal rhythms on BDNF mRNA and protein levels in the visual system, hippocampus, and cerebellum. J. Neurosci. 21 (2001) 3923-3931
100. Posner A. Ischemia and the glaucoma syndrome. The Eye, Ear, Nose and Throat Monthly 37 (1958) 528
101. Quigley H.A. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust. N.Z. J. Ophthalmol. 23 (1995) 85-91
102. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., and Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3460-3466
103. Rao P.V., Deng P.F., Kumar J., and Epstein D.L. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1029-1037
104. Robinson M., Adu J., and Davies A.M. Timing and regulation of TrkB and BDNF mRNA expression in placode-derived sensory neurons and their targets. Eur. J. Neurosci. 8 (1996) 2399-2406
105. Roux P.P., and Barker P.A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 67 (2002) 203-233
106. Rudzinski M., Wong T.P., and Saragovi H.U. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension. J. Neurobiol. 58 (2004) 341-354
107. Sabel B.A., Sautter J., Stoehr T., and Siliprandi R.A. A behavioral model of excitotoxicity: retinal degeneration loss of vision, and subsequent recovery after intraocular NMDA-administration in adult rats. Exp. Brain. Res. 106 (1995) 93-105
108. Saido T.C., Sorimachi H., and Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8 (1994) 814-822
109. Sandoval M., Sandoval R., Thomas U., Spilker C., Small K.H., Falcon R., Marengo J.J., Calderón R., Saavedra V., Heumann R., Bronfman F., Garner C.C., Gundelfinger E.D., and Wyneken U. Antagonistic effects of TrkB and p75(NTR) on NMDA receptor currents in post-synaptic densities transplanted into Xenopus oocytes. J. Neurochem. 101 (2007) 1672-1684
110. Schulman H. Activity-dependent regulation of calcium/calmodulin-dependent protein kinase II localization. J. Neurosci. 24 (2004) 8399-8403
111. Shimomura A., Ogawa Y., Kitani T., Fujisawa H., and Hagiwara M. Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein. J. Biol. Chem. 271 (1996) 17957-17960
112. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato N., Zanoni R., and Vantini G. N-methyl-d-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8 (1991) 567-573
113. Sisk D.R., and Kuwabara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium l-glutamate. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 250-258
114. Stroman G.A., Stewart W.C., Golnik K.C., Curé J.K., and Olinger R.E. Magnetic resonance imaging in patients with low-tension glaucoma. Arch. Ophthalmol. 113 (1995) 168-172
115. Sucher N.J., Lipton S.A., and Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis. Res. 37 (1997) 3483-3493
116. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8 (1994) 2527-2539
117. Sun P., Lou L., and Maurer R.A. Regulation of activating transcription factor-1 and the cAMP response element-binding protein by Ca/calmodulin-dependent protein kinases type I, II, and IV. J. Biol. Chem. 271 (1996) 3066-3073
118. Tan S.E., Robert J.W., and Soderling T.R. Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J. Neurosci. 14 (1994) 1123-1129
119. Tatton W.G. Apoptosis mechanisms in neurodegeneration: possible relevance to glaucoma. Eur. J. Ophthalmol. 9 suppl 1 (1999) S22-S29
120. Tenneti L., and Lipton S.A. Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurosci. 74 (2000) 134-142
121. Terashima T., Ochiishi T., and Yamauchi T. Immunocytochemical localization of calcium/calmodulin-dependent protein kinase II isoforms in the ganglion cells of the rat retina: immunofluorescence histochemistry combined with a fluorescent retrograde tracer. Brain Res. 650 (1994) 133-139
122. Thanos S., Bahr M., Barde Y.A., and Vanselow J. Survival and axonal elongation of adult rat retinal ganglion cells. In vitro effects of lesioned sciatic nerve and brain derived neurotrophic factor. Eur. J. Neurosci. 1 (1989) 19-26
123. Tian B., Gabelt B.T., Peterson J.A., Kiland J.A., and Kaufman P.L. H7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys. Invest. Ophthalmol. Vis. Sci. 40 (1999) 239-242
124. Ullian E.M., Barkis W.B., Chen S., Diamond J.S., and Barres B.A. Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol. Cell. Neurosci. 26 (2004) 544-557
125. Unoki K., and LaVail M.M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest. Ophthalmol. Vis. Sci. 35 (1994) 907-915
126. Vecino E., Caminos E., Ugarte M., Martin-Zanca D., and Osborne N.N. Immunohistochemical distribution of neurotrophins and their receptors in the rat retina and the effects of ischemia and reperfusion. Gen. Pharmacol. 30 (1998) 305-314
127. Vecino E., Garcia-Grespo D., Garcia M., Martinez-Millan L., Sharma S.C., and Carrascal E. Rat retinal ganglion cells co-express brain derived neurotrophic factor (BDNF) and its receptor TrkB. Vis. Res. 42 (2002) 151-157
128. Vecino E., Ugarte M., Nash M.S., and Osborne N.N. NMDA induces BDNF expression in the albino rat retina in vivo. Neuroreport 10 (1999) 1103-1106
129. Vorverk C.K., Gorla M.S., and Dreyer E.B. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv. Ophthalmol. 43 suppl 1 (1999) S142-S150
130. Vorverk C.K., Lipton S.A., Zurakowski D., Hyman B.T., and Sabel B.A. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1618-1624
131. Waldmann E., Gasser P., Dubler B., Huber C., and Flammer J. Silent myocardial ischemia in glaucoma and cataract patients. Graefes. Arch. Clin. Exp. Ophthalmol. 234 (1996) 595-598
132. Waki M., Yoshida Y., Oka T., and Azuma M. Reduction of intarocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr. Eye Res. 22 (2001) 470-474
133. Wegner M., Cao Z., and Rosenfeld M.G. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science 256 (1992) 370-373
134. Xue J., Li G., Laabich A., and Cooper N.G. Visual-mediated regulation of retinal CaMKII and its GluR1 substrate is age-dependent. Brain Res. Mol. Brain Res. 93 (2001) 95-104
135. Yamamoto T. The dawn of neuroprotective therapy for glaucomatous optic neuropathy. Nippon Ganka Gakkai Zasshi 105 (2001) 866-883
136. Yano S., Fukunaga K., Takiguchi M., Ushio Y., Mori M., and Miyamoto E. Regulation of CCAAT/Enhancer-binding protein family members by stimulation of glutamate receptors in cultured rat cortical astrocytes. J. Biol. Chem. 271 (1996) 23520-23527